{"url":"https://lda.senate.gov/api/v1/filings/200b66e8-3dac-4b4e-b2f1-4e7c2ab23a3a/","filing_uuid":"200b66e8-3dac-4b4e-b2f1-4e7c2ab23a3a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2023,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/200b66e8-3dac-4b4e-b2f1-4e7c2ab23a3a/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jack S. Deuser, President & CEO","dt_posted":"2023-10-20T10:22:19-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 K Street NW Suite 1200","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":35800,"url":"https://lda.senate.gov/api/v1/registrants/35800/","house_registrant_id":30770,"name":"THE SMITH-FREE GROUP, LLC","description":"Government relations and business consulting","address_1":"1001 G Street NW","address_2":"Suite 375 West","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN CHRISTIE","contact_telephone":"+1 202-393-4760","dt_updated":"2026-01-30T13:49:07.819808-05:00"},"client":{"id":205949,"url":"https://lda.senate.gov/api/v1/clients/205949/","client_id":1004303,"name":"GVB BIOPHARMA","general_description":"CBD extraction and distillation","client_government_entity":false,"client_self_select":null,"state":"NV","state_display":"Nevada","country":"US","country_display":"United States of America","ppb_state":"NV","ppb_state_display":"Nevada","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-07-01"},"lobbying_activities":[{"general_issue_code":"AGR","general_issue_code_display":"Agriculture","description":"Discussions relating to regulation of the CBD industry Discussions relating to Farm Bill Reauthorization Discussions relating to regulation of Delta-8 THC Monitored H.R. 2891, the SAFE Banking Act of 2023 Monitored S. 1323, the SAFE Banking Act of 2023 Monitored S. 2860, the SAFER Banking Act Monitored discussions related to providing banking services to a legitimate cannabis-related business Monitored H.R. 4368, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 Monitored executive branch nominations to federal agencies and commissions","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143170,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"CHRISTIE","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":107000,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"A.","last_name":"GAFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63331,"prefix":null,"prefix_display":null,"first_name":"TREVOR","nickname":null,"middle_name":"W.","last_name":"KOLEGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}